← Evidence map

ReviewCells2025

TRIM25: A Global Player of Cell Death Pathways and Promising Target of Tumor-Sensitizing Therapies.

Wolfgang Eberhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39851496